The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer-Reference-Cited by-同舟云学术

The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer

Published:2013-04-08 Issue:6 Volume:133 Page:1408-1418
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Thornton Michael,Aslam Mohammed A.¹,Tweedle Elizabeth M.,Ang Chin¹,Campbell Fiona²,Jackson Richard³,Costello Eithne¹,Rooney Paul S.⁴,Vlatković Nikolina¹,Boyd Mark T.¹

Affiliation:

1. Department of Molecular and Clinical Cancer Medicine; University of Liverpool; L3 9TA; United Kingdom

2. Department of Pathology; Royal Liverpool University Hospital; Prescott St, Liverpool L7 8XP; United Kingdom

3. Bioinformatics Group; Liverpool Cancer Trials Unit; Liverpool; Block C Waterhouse Building, L69 3GL; United Kingdom

4. Department of Surgery; Royal Liverpool University Hospital; Prescott St, Liverpool L7 8XP; United Kingdom

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer;O'Connell;J Clin Oncol,1997

3. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial;Andre;J Clin Oncol,2009

4. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07;Kuebler;J Clin Oncol,2007

5. Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy;Twelves;Ann Oncol,2011

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting PERK and GRP78 in colorectal cancer: Genetic insights and novel therapeutic approaches;European Journal of Pharmacology;2024-11

2. 14‐3‐3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer;International Journal of Cancer;2024-09-06

3. Corilagin enhances the anti-tumor activity of 5-FU by downregulating the expression of GRP 78;Scientific Reports;2023-12-19

4. Recent advances in small molecule and peptide inhibitors of glucose-regulated protein 78 for cancer therapy;European Journal of Medicinal Chemistry;2023-12

5. Reactive Oxygen Species as Mediators of Disease Progression and Therapeutic Response in Colorectal Cancer;Antioxidants & Redox Signaling;2023-07-01